Delsitech Ltd

Delsitech Ltd company information, Employees & Contact Information

Explore related pages

Related company profiles:

DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend and manage the life cycle of existing products. More patient-friendly products can be developed which release active compounds over days to many months. The technology is also well suited for challenging drug delivery needs such as controlled local delivery to the eye or the brain. At DelSiTech, we are also developing our own in-house supergeneric drug products for significant unmet medical and market needs.

Company Details

Employees
60
Founded
-
Address
Itäinen Pitkäkatu 4 C, Turku,southwest Finland 20520,finland
Phone
+358 2 2510 110
Email
in****@****ech.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Turku, Southwest Finland
Looking for a particular Delsitech Ltd employee's phone or email?

Delsitech Ltd Questions

News

Finland's DelSiTech secures €10 million to propel silica-based drug delivery technology into clinical - ArcticStartup

Finland's DelSiTech secures €10 million to propel silica-based drug delivery technology into clinical ArcticStartup

DelSiTech and Tolmar International Sign Global License & Development Agreement - Contract Pharma

DelSiTech and Tolmar International Sign Global License & Development Agreement Contract Pharma

This Biotech Reduces Drug Side Effects Using Silica Gel Implants - Labiotech.eu

This Biotech Reduces Drug Side Effects Using Silica Gel Implants Labiotech.eu

DelSiTech: leveraging silica’s properties to improve drug delivery - Pharmaceutical Technology

DelSiTech: leveraging silica’s properties to improve drug delivery Pharmaceutical Technology

Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration - ACS Publications

Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration ACS Publications

Zimura 2.0: Iveric taps DelSiTech to develop sustained-release form of retinal disease prospect - Fierce Pharma

Zimura 2.0: Iveric taps DelSiTech to develop sustained-release form of retinal disease prospect Fierce Pharma

Finland’s DelSiTech closes a €10M round for its drug delivery platform - en.ain.ua

Finland’s DelSiTech closes a €10M round for its drug delivery platform en.ain.ua

Bayer signs up DelSiTech ophthalmology drug delivery technology - Fierce Pharma

Bayer signs up DelSiTech ophthalmology drug delivery technology Fierce Pharma

Finland’s biotech stars: 9 names you will want to remember - Labiotech.eu

Finland’s biotech stars: 9 names you will want to remember Labiotech.eu

Top Delsitech Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant